학술논문

Safety and Immunogenicity of a Novel Intranasal Influenza Vaccine (NasoVAX): A Phase 2 Randomized, Controlled Trial
Document Type
Journal
Source
VACCINES; MAR 2021, 9 3, p224 15p.
Subject
Language
English
ISSN
2076393X